CoChat

Characterizing abdominal pain in IBS: guidance for study inclusion criteria, outcome measurement and clinical practice

Open access
Spiegel, B. M. R., Bolus, R., Harris, L. A., Lucak, S., Chey, W. D., Sayuk, G., Esrailian, E., Lembo, A., Karsan, H., Tillisch, K., Talley, J., Chang, L. · 2010 · Alimentary Pharmacology & Therapeutics
Cited by 35

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Aliment Pharmacol Ther 2010; 32: 1192–1202 Summary: Background Although irritable bowel syndrome (IBS) is a multisymptom disorder, abdominal pain drives illness severity more than other symptoms. Despite consensus that IBS trials should measure pain to define study entry and determine efficacy, the optimal method of measuring pain remains uncertain. Aim To determine whether combining information from multiple pain dimensions may capture the IBS illness experience more effectively than the approach of measuring ‘pain predominance’ or pain intensity alone. Methods Irritable bowel syndrome patients rated dimensions of pain, including intensity, frequency, constancy, predominance, predictability, duration, speed of onset and relationship to bowel movements. We evaluated the impact of each dimension on illness severity using multivariable regression techniques. Results Among the pain dimensions, intensity, frequency, constancy and predictability were strongly and independently associated with illness severity; the other dimensions had weaker associations. The clinical definition of ‘pain predominance’, in which patients define pain as their most bothersome symptom, was insufficient to categorize patients by illness severity. Conclusions Irritable bowel disease pain is multifaceted; some pain dimensions drive illness more than others. IBS trials should measure various pain dimensions, including intensity, constancy, frequency and predictability; this may improve upon the customary use of measuring pain as a unidimensional symptom in IBS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2036.2010.04443.x

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 35

Metadata

Authors
Spiegel, B. M. R., Bolus, R., Harris, L. A., Lucak, S., Chey, W. D., Sayuk, G., Esrailian, E., Lembo, A., Karsan, H., Tillisch, K., Talley, J., & Chang, L.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2010-08-30
Volume
32
Issue
9
Pages
1192-1202
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W1648481394
Cited by
35
References
8
FWCI
2.31
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Characterizing abdominal pain in IBS: guidance for study inclusion criteria, outcome measurement and clinical practice. https://app.cochat.ai/papers/10.1111/j.1365-2036.2010.04443.x
The paper
Spiegel, B. M. R., Bolus, R., Harris, L. A., Lucak, S., Chey, W. D., Sayuk, G., Esrailian, E., Lembo, A., Karsan, H., Tillisch, K., Talley, J., & Chang, L. (2010). Characterizing abdominal pain in IBS: guidance for study inclusion criteria, outcome measurement and clinical practice. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2010.04443.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.